Halozyme to Report First Quarter 2026 Financial and Operating Results

SAN DIEGO, April 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced it will release its first quarter 2026 financial and operating results on Monday, May 11, 2026, following the close of trading. Halozyme will host a conference call on Monday,...